Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis

Table 1 Patient characteristics

Age (yr)	Sex	HCC	Background liver histology at time of HCC treatment	AFP (IU/L)	HCV status	HBV status	Alcohol (U/wk)
53	M	3.5 cm	Minimal inflammation	239	RNA positive	HBsAg negative	10-30
		Moderate/poor differentiation	Moderate fibrosis		Genotype 1	Anti-HBc positive
		Vascular invasion
57	M	3.1 cm	Mild inflammation	3	RNA positive	HBsAg negative	0
		Moderate differentiation	Mild fibrosis		Genotype 3	Anti-HBc positive
		No vascular invasion
67	F	4.5 cm	Moderate inflammation	206	RNA positive	HBsAg negative	0
		Moderate/poor differentiation	Moderate fibrosis		Genotype 1	Anti-HBc positive
		Lymphovascular invasion
52	M	1.7 cm	Moderate inflammation	77	RNA positive	HBsAg negative	20
		Moderate differentiation	Bridging fibrosis		Genotype 3	Anti-HBc positive
		No vascular invasion
46	M	3 cm	Moderate inflammation	5	RNA positive	Negative	0
		Poorly differentiated with satellite lesions	Moderate fibrosis		Genotype 1
62	M	6.5 cm	Moderate inflammation	10	RNA positive	Negative	30
		Moderate differentiation	Moderate fibrosis		Genotype 1
		Vascular invasion

HCC: Hepatocellular carcinoma; AFP: α-foetoprotein; HCV: Hepatitis C virus; HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen.